Early prevention by L-Arginine attenuates coronary atherosclerosis in a model of hypercholesterolemic animals; No positive results for treatment

Nutrition and Metabolism

Volumn 6, Issue , 2009, Pages

  Javanmard, Shaghayegh Haghjooy ^a   Nematbakhsh, Mehdi ^a   Sanei, Mohammad Hosein ^a  

^a ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

[No Author keywords available]

Indexed keywords

ARGININE; BIOLOGICAL MARKER; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPOPROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; NITRITE; TRIACYLGLYCEROL; VON WILLEBRAND FACTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BODY WEIGHT; CHOLESTEROL DIET; CONTROLLED STUDY; CORONARY ARTERY ATHEROSCLEROSIS; DIET SUPPLEMENTATION; ENDOTHELIAL DYSFUNCTION; HYPERCHOLESTEROLEMIA; LIPID BLOOD LEVEL; MALE; NONHUMAN; OUTCOME ASSESSMENT; PROTEIN SECRETION; RABBIT;

ANIMALIA; ORYCTOLAGUS CUNICULUS;

EID: 64249106692     PISSN: None     EISSN: 17437075     Source Type: Journal    
DOI: 10.1186/1743-7075-6-13     Document Type: Article

References (35)

1. Global mortality, disability, and the contribution of risk factors: Global Burden of Disease Study. CJ Murray AD Lopez, Lancet 1997 349 9063 1436 1442 10.1016/S0140-6736(96)07495-8 9164317
2. Influence of cardiovascular risk factors on endothelial progenitor cells: limitations for therapy? N Werner G Nickenig, Arterioscler Thromb Vasc Biol 2006 26 2 257 266 10.1161/01.ATV.0000198239.41189.5d 16322535
3. Prevention of atherosclerosis in childhood. GS Berenson SR Srinivasan, Lancet 1999 354 9186 1223 1224 10.1016/S0140-6736(99)00274-3 10520626
4. Rethinking primary prevention of atherosclerosis-related diseases. C Napoli LO Lerman F de Nigris M Gossl ML Balestrieri A Lerman, Circulation 2006 114 23 2517 2527 10.1161/CIRCULATIONAHA.105.570358 17146003
5. Fatty streak formation occurs in human fetal aortas and is greatly enhanced by maternal hypercholesterolemia. Intimal accumulation of low density lipoprotein and its oxidation precede monocyte recruitment into early atherosclerotic lesions. C Napoli FP D'Armiento FP Mancini A Postiglione JL Witztum G Palumbo W Palinski, J Clin Invest 1997 100 11 2680 2690 9389731 10.1172/JCI119813
6. Vascular endothelium summary statement II: Cardiovascular disease prevention and control. GA Mensah US Ryan WC Hooper MM Engelgau AD Callow GK Kapuku A Mantovani, Vascul Pharmacol 2007 46 5 318 320 10.1016/j.vph.2006.10.019 17229595
7. Endothelial dysfunction: a marker of atherosclerotic risk. PO Bonetti LO Lerman A Lerman, Arterioscler Thromb Vasc Biol 2003 23 2 168 175 10.1161/01.ATV.0000051384.43104.FC 12588755
8. Novel features of nitric oxide, endothelial nitric oxide synthase, and atherosclerosis. LJ Ignarro C Napoli, Curr Diab Rep 2005 5 1 17 23 10.1007/s11892-005-0062-8 15663912
9. Mechanisms of dysfunction of the nitric oxide pathway in vascular diseases. AJ Maxwell, Nitric Oxide 2002 6 2 101 124 10.1006/niox.2001.0394 11890735
10. Nitric oxide and atherosclerosis: an update. C Napoli F de Nigris S Williams-Ignarro O Pignalosa V Sica LJ Ignarro, Nitric Oxide 2006 15 4 265 279 10.1016/j.niox.2006.03.011 16684613
11. The L-arginine nitric oxide pathway: avenue for a multiple-level approach to assess vascular function. T Rassaf P Kleinbongard M Kelm, Biol Chem 2006 387 1011 1347 1349 10.1515/BC.2006.168 17081105
12. Nitric oxide donor drugs: current status and future trends. IL Megson DJ Webb, Expert Opin Investig Drugs 2002 11 5 587 601 10.1517/13543784.11.5.587 11996642
13. Recent developments in nitric oxide donor drugs. MR Miller IL Megson, Br J Pharmacol 2007 151 3 305 321 17401442 10.1038/sj.bjp.0707224
14. Dietary L-arginine reduces the progression of atherosclerosis in cholesterol-fed rabbits: comparison with lovastatin. RH Boger SM Bode-Boger RP Brandes L Phivthong-ngam M Bohme R Nafe A Mügge JC Frölich, Circulation 1997 96 4 1282 1290 9286960
15. Arginine: a new therapy for atherosclerosis? JP Cooke PS Tsao, Circulation 1997 95 2 311 312 9008440
16. Arginine and endothelial and vascular health. HL Gornik MA Creager, J Nutr 2004 134 Suppl 10 2880S 2887S 15465805
17. l-Citrulline and l-arginine supplementation retards the progression of high-cholesterol-diet-induced atherosclerosis in rabbits. T Hayashi PA Juliet H Matsui-Hirai A Miyazaki A Fukatsu J Funami A Iguchi LJ Ignarro, Proc Natl Acad Sci USA 2005 102 38 13681 13686 16157883 10.1073/pnas.0506595102
18. Mechanisms of disease: L-arginine in coronary atherosclerosis a clinical perspective. D Tousoulis RH Boger C Antoniades G Siasos E Stefanadi C Stefanadis, Nat Clin Pract Cardiovasc Med 2007 4 5 274 283 10.1038/ncpcardio0878 17457351
19. L-arginine therapy in acute myocardial infarction: the Vascular Interaction With Age in Myocardial Infarction (VINTAGE MI) randomized clinical trial. SP Schulman LC Becker DA Kass HC Champion ML Terrin S Forman KV Ernst MD Kelemen SN Townsend A Capriotti JM Hare G Gerstenblith, JAMA 2006 295 1 58 64 10.1001/jama.295.1.58 16391217
20. Cholesterol vehicle in experimental atherosclerosis 24: avocado oil. D Kritchevsky SA Tepper S Wright SK Czarnecki TA Wilson RJ Nicolosi, J Am Coll Nutr 2003 22 1 52 5 12569114
21. von willebrand factor, C-reactive protein, nitric oxide, and vascular endothelial growth factor in a dietary reversal model of hypercholesterolemic rabbit. Sh Haghjooyjavanmard M Nematbakhsh A Monajemi M Soleimani, Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub 2008 152 1 91 95 18795081
22. L-arginine supplementation influenced nitrite but not nitrate and total nitrite in rabbit model of hypercholesterolemia. S Haghjooy Javanmard M Nematbakhsh A Monajemi, Iran Biomed J 2008 12 3 179 84 18762822
23. Novel insights into coronary lumen preservation during progression of coronary atherosclerosis in coronary atherosclerosis-prone rabbits. M Shiomi T Ito M Hasegawa K Yoshida KL Gould, Coron Artery Dis 2004 15 7 419 426 10.1097/00019501-200411000-00009 15492591
24. High dietary methionine plus cholesterol exacerbates atherosclerosis formation in the left main coronary artery of rabbits. A Zulli DL Hare BF Buxton MJ Black, Atherosclerosis 2004 176 1 83 89 10.1016/j.atherosclerosis.2004.05. 013 15306178
25. Dietary arginine prevents atherogenesis in the coronary artery of the hypercholesterolemic rabbit. BY Wang AH Singer PS Tsao H Drexler J Kosek JP Cooke, J Am Coll Cardiol 1994 23 2 452 8 8294700
26. Chylomicron metabolism in normal, cholesterol-fed, and Watanabe heritable hyperlipidemic rabbits Saturation of the sequestration step of the remnant clearance pathway. MM Hussain TL Innerarity WJ Brecht RW Mahley, J Biol Chem 1995 270 15 8578 87 10.1074/jbc.270.15.8578 7721759
27. Chronic dietary supplementation with L-arginine inhibits platelet aggregation and thromboxane A2 synthesis in hypercholesterolaemic rabbits in vivo. SM Bode-Böger RH Böger S Kienke M Böhme L Phivthong-ngam D Tsikas JC Frölich, Cardiovasc Res 1998 37 3 756 64 10.1016/S0008-6363(97) 00295-2 9659460
28. Enhanced endothelial adhesiveness in hypercholesterolemia is attenuated by L-arginine. PS Tsao LM McEvoy H Drexler EC Butcher JP Cooke, Circulation 1994 89 5 2176 82 8181143
29. l-Arginine supplementation enhances eNOS expression in experimental model of hypercholesterolemic rabbits aorta. SH Javanmard M Nematbakhsh F Mahmoodi MR Mohajeri, Pathophysiology 2009 19168337
30. Adverse effects of supplemental L-arginine in atherosclerosis: consequences of methylation stress in a complex catabolism? J Loscalzo, Arterioscler Thromb Vasc Biol 2003 23 1 3 5 10.1161/01.ATV.0000040860.71626.9D 12524215
31. Endothelium-dependent vasodilation is independent of the plasma L arginine/ADMA ratio in men with stable angina: lack of effect of oral L-arginine on endothelialfunction, oxidative stress and exercise performance. HA Walker E McGing I Fisher RH Böger SM Bode-Böger G Jackson JM Ritter PJ Chowienczyk, J Am Coll Cardiol 2001 38 2 499 505 10.1016/S0735-1097(01)01380-8 11499744
32. Arginine intake and risk of coronary heart disease mortality in elderly men. CM Oomen MJ van Erk EJ Feskens FJ Kok D Kromhout, Arterioscler Thromb Vasc Biol 2000 20 9 2134 2139 10978260
33. Neonatal intima formation in the human coronary artery. Y Ikari BM McManus J Kenyon SM Schwartz, Arterioscler Thromb Vasc Biol 1999 19 9 2036 2040 10479643
34. Maternal hypercholesterolemia enhances atherogenesis in normocholesterolemic rabbits, which is inhibited by antioxidant or lipid-lowering intervention during pregnancy: an experimental model of atherogenic mechanisms in human fetuses. C Napoli JL Witztum F Calara F de Nigris W Palinski, Circ Res 2000 87 10 946 952 11073892
35. Maternal hypercholesterolemia during pregnancy promotes early atherogenesis in LDL receptor-deficient mice and alters aortic gene expression determined by microarray. C Napoli F de Nigris JS Welch FB Calara RO Stuart CK Glass W Palinski, Circulation 2002 105 11 1360 1367 10.1161/hc1102.106792 11901049